AstraZeneca 2Q: Soriot's In It For The Long Haul
Executive Summary
AstraZeneca's CEO used the company's second-quarter earnings call to proclaim his commitment to the business just weeks after rumors spread worldwide that he might take up a vacant chief executive role at a rival firm.